JP3565332B2 - Emulsion type solid cosmetic - Google Patents
Emulsion type solid cosmetic Download PDFInfo
- Publication number
- JP3565332B2 JP3565332B2 JP2000296372A JP2000296372A JP3565332B2 JP 3565332 B2 JP3565332 B2 JP 3565332B2 JP 2000296372 A JP2000296372 A JP 2000296372A JP 2000296372 A JP2000296372 A JP 2000296372A JP 3565332 B2 JP3565332 B2 JP 3565332B2
- Authority
- JP
- Japan
- Prior art keywords
- sucrose
- fatty acid
- carbon atoms
- monoester
- glyceryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007787 solid Substances 0.000 title claims description 29
- 239000002537 cosmetic Substances 0.000 title claims description 21
- 239000000839 emulsion Substances 0.000 title 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 38
- 229930006000 Sucrose Natural products 0.000 claims description 38
- 239000005720 sucrose Substances 0.000 claims description 38
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 15
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 11
- 239000006071 cream Substances 0.000 description 20
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 239000012071 phase Substances 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- -1 etc. Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 229940070765 laurate Drugs 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 229940075466 undecylenate Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 125000005472 straight-chain saturated fatty acid group Chemical group 0.000 description 4
- 229940032085 sucrose monolaurate Drugs 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- QIZPVNNYFKFJAD-UHFFFAOYSA-N 1-chloro-2-prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1Cl QIZPVNNYFKFJAD-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- 229940035023 sucrose monostearate Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 2
- XZAGBDSOKNXTDT-UHFFFAOYSA-N Sucrose monopalmitate Chemical compound CCCCCCCCCCCCCCCC(O)=O.OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(CO)O1 XZAGBDSOKNXTDT-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940081618 glyceryl monobehenate Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【０００１】
【発明の属する技術分野】
本発明は、低温下における硬度上昇や経時的な硬度上昇が改善されて製剤安定性に優れ、しかも皮膚に対し低刺激性である乳化型固形化粧料に関する。さらに詳しくは、（Ａ）ショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステル、（Ｂ）炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステル、及び常温で固形状を呈する油性物質を含有する乳化化粧料において、（Ｃ）ショ糖と炭素数が１４以下の脂肪酸とのモノエステル及び（Ｄ）炭素数が１４以下の脂肪酸のポリグリセリルモノエステルより成る群から選択される１種又は２種以上を、さらに含有して成る乳化型固形化粧料に関する。
【０００２】
【従来の技術】
エモリエントクリーム，マッサージクリーム，クレンジングクリーム，メイクアップクリーム等に代表される乳化型固形化粧料においては、化粧料の硬度を保持するため、常温で固形状を呈する油脂類やロウ類などが汎用される。また、皮膚に対し低刺激性であることや、生分解性が良好であることなどから、ショ糖の脂肪酸エステルやグリセリン等多価アルコールの脂肪酸エステルといった非イオン性界面活性剤の使用が検討されてきた。酸化安定性を維持し、化粧料の形状を固形状に保つ上で、これらを構成する脂肪酸については、炭素数が１６以上の直鎖状で飽和のものが主に使用されてきた。
【０００３】
しかしながら、ショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステル、及び炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステルを用い、さらに常温で固形状を呈する油脂類やロウ類等を含有させて成る乳化型の固形化粧料においては、低温下において硬度が上昇し、また経時的にも硬度の上昇が見られ、製剤安定性の上で大きな問題となっていた。
【０００４】
【発明が解決しようとする課題】
そこで本発明においては、ショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステル、炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステル、及び常温で固形状を呈する油性物質を含有して成る乳化型固形化粧料における、上記したような低温下又は経時における硬度上昇を抑制し、製剤安定性が良好で、しかも皮膚に対し低刺激性である乳化型の固形化粧料を得ることを目的とした。
【０００５】
【課題を解決するための手段】
上記課題を解決するため種々検討した結果、（Ａ）ショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステル、（Ｂ）炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステル、及び常温で固形状を呈する油性物質を含有する乳化化粧料に、（Ｃ）ショ糖と炭素数が１４以下の脂肪酸とのモノエステル及び（Ｄ）炭素数が１４以下の脂肪酸のポリグリセリルモノエステルより成る群から選択される１種又は２種以上をさらに含有させることにより、低温下における硬度上昇及び経時的な硬度上昇を有効に抑制することができ、しかも皮膚に対する刺激性も低いことを見いだし、本発明を完成するに至った。
【０００６】
【発明の実施の形態】
本発明において、（Ａ）成分として用いるショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステルとしては、ショ糖モノパルミチン酸エステル，ショ糖モノマルガリン酸エステル，ショ糖モノステアリン酸エステル，ショ糖モノアラキン酸エステル，ショ糖モノベヘン酸エステル，ショ糖モノリグノセリン酸エステル等が挙げられ、これらの中でも、炭素数が１６〜２２のものが好ましく用いられる。
【０００７】
また、（Ｂ）成分として用いる炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステルとしては、モノパルミチン酸グリセリル，モノマルガリン酸グリセリル，モノステアリン酸グリセリル，モノアラキン酸グリセリル，モノベヘン酸グリセリル，モノリグノセリン酸グリセリル等が挙げられ、これらの中でも、炭素数が１６〜２２のものが好ましく用いられる。
【０００８】
本発明において用いる常温で固形状を呈する油性物質としては、モクロウ，牛脂，硬化牛脂，硬化大豆油，硬化ヒマシ油等の固形状油脂類、カルナウバロウ，キャンデリラロウ，水添ホホバ油等の植物ロウ類、ミツロウ，鯨ロウ，ラノリン，還元ラノリン，硬質ラノリン等の動物ロウ類、オゾケライト，セレシン，マイクロクリスタリンワックス等の固形状炭化水素類、トリ牛脂脂肪酸グリセリル，トリステアリン酸グリセリル，トリパルミチン酸グリセリル，トリベヘン酸グリセリル，トリミリスチン酸グリセリル，トリヤシ油脂肪酸グリセリル，トリラウリン酸グリセリル，トリラノリン脂肪酸グリセリル等の固形状脂肪酸トリグリセリドなどが挙げられる。
【０００９】
次に、本発明において上記した（Ａ），（Ｂ）成分及び常温で固形状を呈する油性物質と併用する（Ｃ）のショ糖と炭素数が１４以下の脂肪酸とのモノエステルとしては、ショ糖モノカプリン酸エステル，ショ糖モノウンデカン酸エステル，ショ糖モノラウリン酸エステル，ショ糖モノトリデカン酸エステル，ショ糖モノミリスチン酸エステル，ショ糖モノカプロレイン酸エステル，ショ糖モノ９−ウンデシレン酸エステル，ショ糖モノ１０−ウンデシレン酸エステル，ショ糖モノ２−ラウロレイン酸エステル，ショ糖モノリンデル酸エステル，ショ糖モノトウハク酸エステル，ショ糖モノ５−ラウロレイン酸エステル，ショ糖モノ１１−ラウロレイン酸エステル，ショ糖モノ２−トリデセン酸エステル，ショ糖モノｃｉｓ−９−トリデセン酸エステル，ショ糖モノ１２−トリデセン酸エステル，ショ糖モノツズ酸エステル，ショ糖モノ５−ミリストレイン酸エステル，ショ糖モノ９−ミリストレイン酸エステル等が挙げられる。これらの中でも、ＨＬＢ値が１２以上のものが好ましく、また脂肪酸の炭素数が１２〜１４のものが好ましい。
【００１０】
また、本発明において上記（Ａ），（Ｂ）成分及び常温で固形状を呈する油性物質と併用する（Ｄ）の炭素数が１４以下の脂肪酸のポリグリセリルモノエステルとしては、モノカプリン酸ヘキサグリセリル，モノウンデカン酸ヘキサグリセリル，モノラウリン酸ヘキサグリセリル，モノトリデカン酸ヘキサグリセリル，モノミリスチン酸ヘキサグリセリル，モノカプロレイン酸ヘキサグリセリル，モノ９−ウンデシレン酸ヘキサグリセリル，モノ１０−ウンデシレン酸ヘキサグリセリル，モノ２−ラウロレイン酸ヘキサグリセリル，モノリンデル酸ヘキサグリセリル，モノトウハク酸ヘキサグリセリル，モノ５−ラウロレイン酸ヘキサグリセリル，モノ１１−ラウロレイン酸ヘキサグリセリル，モノ２−トリデセン酸ヘキサグリセリル，モノｃｉｓ−９−トリデセン酸ヘキサグリセリル，モノ１２−トリデセン酸ヘキサグリセリル，モノツズ酸ヘキサグリセリル，モノ５−ミリストレイン酸ヘキサグリセリル，モノ９−ミリストレイン酸ヘキサグリセリル，モノカプリン酸デカグリセリル，モノウンデカン酸デカグリセリル，モノラウリン酸デカグリセリル，モノトリデカン酸デカグリセリル，モノミリスチン酸デカグリセリル，モノカプロレイン酸デカグリセリル，モノ９−ウンデシレン酸デカグリセリル，モノ１０−ウンデシレン酸デカグリセリル，モノ２−ラウロレイン酸デカグリセリル，モノリンデル酸デカグリセリル，モノトウハク酸デカグリセリル，モノ５−ラウロレイン酸デカグリセリル，モノ１１−ラウロレイン酸デカグリセリル，モノ２−トリデセン酸デカグリセリル，モノｃｉｓ−９−トリデセン酸デカグリセリル，モノ１２−トリデセン酸デカグリセリル，モノツズ酸デカグリセリル，モノ５−ミリストレイン酸デカグリセリル，モノ９−ミリストレイン酸デカグリセリル等が挙げられる。これらの中でも、ＨＬＢ値が１２以上のものが好ましく、また脂肪酸の炭素数が１２〜１４のものが好ましい。
【００１１】
本発明においては、上記（Ｃ）及び（Ｄ）より成る群から１種又は２種以上を選択し、（Ａ），（Ｂ）成分及び常温で固形状を呈する油性物質と併用して用いる。本発明に係る乳化型固形化粧料においては、（Ａ）成分と（Ｃ）成分を合わせて１．０〜１０．０重量％、（Ｂ）成分を１．０〜５．０重量％、常温で固形状を呈する油性物質を１．０〜１０．０重量％（さらに好ましくは３．０〜８．０重量％）、（Ｄ）成分を０．１〜５．０重量％含有させることが好ましい。また、（Ａ）と（Ｃ）との重量比及び（Ａ）と（Ｄ）との重量比を、それぞれ８：１〜１：１とすることが好ましい。
【００１２】
本発明に係る乳化型固形化粧料は、エモリエントクリーム，マッサージクリーム等の皮膚用化粧料、クレンジングクリーム等の洗浄用化粧料、メイクアップクリーム，ベースクリーム等の下地化粧料、サンスクリーンクリーム，サンタンクリーム等の日焼け止めもしくは日焼け用化粧料、ヘアクリーム等の毛髪用化粧料、ハンドクリーム，ネッククリーム，レッグクリーム等の身体用化粧料などとして提供され得る。
【００１３】
さらに本発明に係る乳化型固形化粧料においては、上記（Ａ）〜（Ｄ）の各成分及び常温で固形状を呈する油性物質の他に、本発明の特徴を損なわない範囲で、油脂，炭化水素油，エステル油，高級アルコール等の他の油性成分、他の界面活性剤、多価アルコール，アミノ酸等の保湿剤、水溶性高分子化合物、防菌防黴剤、抗酸化剤、塩基成分等、一般的な化粧料用成分を含有させることができる。
【００１４】
【実施例】
さらに本発明の特徴について、実施例により詳細に説明する。
【００１５】
［実施例１〜実施例７］ マッサージクリーム
以下に示す処方により、本発明に係るマッサージクリームとして、実施例１〜実施例７を調製した。また、同時に比較例１〜比較例３を調製した。
（１）ミツロウ ６．００（重量％）
（２）スクワラン ３３．００
（３）オクタン酸セチル １６．００
（４）ベヘニルアルコール １．００
（５）表１に示す（Ｂ）成分 表１に示す量
（６）表１に示す（Ａ）成分 表１に示す量
（７）表１に示す（Ｃ）成分 表１に示す量
（８）表１に示す（Ｄ）成分 表１に示す量
（９）Ｎ−ステアロイル−Ｌ−グルタミン酸ナトリウム ０．３０
（１０）１，３−ブチレングリコール ６．００
（１１）カルボキシビニルポリマー ０．２０
（１２）パラオキシ安息香酸メチル ０．０５
（１３）Ｌ−アルギニン ０．２５
（１４）精製水 全量を１００．００とする量
製法：（１）〜（５）の油相成分を混合して加熱溶解し、７５℃とする。（１３）を（１４）の一部に溶解して水溶液とする。（６）〜（１２）を（１４）の残部に添加溶解して、７５℃に加熱し、これに前記油相成分を添加，混合してホモジナイザーにより均一に乳化し、（１３）の水溶液を添加，混合した後、冷却する。
【００１６】
【表１】
上記実施例１〜実施例７及び比較例１〜比較例３について、低温下における硬度変化と経時的な硬度変化を観察した。まず、実施例及び比較例のそれぞれを２５℃及び５℃の各温度にて２４時間静置した後、不動工業株式会社製レオメーターにて硬度を測定し、次いで２５℃で３カ月間静置した後の硬度を同様に測定して、それぞれの測定値を比較した。結果は表２に示す。
【００１８】
【表２】
低温時における硬度変化としては、５℃にて２４時間静置後の硬度が５００を超えると使用性が低下する。また、硬度の経時変化としては、２５℃にて３カ月間静置後の硬度が２００を超えると、使用上問題となる。表２より明らかなように、本発明の実施例１〜実施例７については、５℃，２４時間静置後の硬度が１７２〜４５０であり、２５℃，３カ月間静置後の硬度についても５１〜９８と、硬度の上昇は使用上問題のない範囲内に抑制されていた。これに対し、比較例１〜比較例３はすべて２５℃，３カ月間静置後の硬度が２００を超えており、比較例１及び比較例２については、５℃，２４時間静置後の硬度上昇も顕著に認められていた。
【００２０】
続いて、本発明に係る他の実施例の処方を示す。
【００２１】
［実施例８］ エモリエントクリーム
（１）ミツロウ ６．０（重量％）
（２）スクワラン ２５．０
（３）ホホバ油 ５．０
（４）ミリスチン酸イソセチル １５．０
（５）モノステアリン酸グリセリル ２．０
（６）ショ糖モノステアリン酸エステル ４．０
（７）ショ糖モノラウリン酸エステル １．５
（８）モノラウリン酸デカグリセリル ０．５
（９）１，３−ブチレングリコール ６．０
（１０）グリセリン ４．０
（１１）パラオキシ安息香酸メチル ０．１
（１２）精製水 ３０．７
（１３）ヒアルロン酸ナトリウム１．０重量％水溶液 ０．１
（１４）香料 ０．１
製法：（１）〜（５）の油相成分を混合，加熱溶解して、７５℃とする。一方、（６）〜（１２）の水相成分を混合，溶解して７５℃とし、これに前記油相成分を加えて混合し、ホモジナイザーにて均一に乳化する。次いで冷却し、４０℃にて（１３），（１４）を添加，混合する。
【００２２】
［実施例９］ クレンジングクリーム
（１）カルナウバロウ ５．０（重量％）
（２）ワセリン １０．０
（３）流動パラフィン ３８．０
（４）ミリスチン酸イソプロピル １０．０
（５）モノステアリン酸グリセリル ２．５
（６）ポリオキシエチレン（２０Ｅ．Ｏ．）ソルビタン ０．５
モノステアリン酸エステル
（７）ショ糖モノパルミチン酸エステル ５．０
（８）モノラウリン酸ヘキサグリセリル １．５
（９）モノミリスチン酸デカグリセリル １．５
（１０）プロピレングリコール ５．０
（１１）パラオキシ安息香酸メチル ０．１
（１２）精製水 ２０．８
（１３）香料 ０．１
製法：（１）〜（６）の油相成分を混合，加熱溶解して、７５℃とする。一方、（７）〜（１２）の水相成分を混合，溶解して７５℃とし、これに前記油相成分を加えて混合し、ホモジナイザーにて均一に乳化する。次いで冷却し、４０℃にて（１３）を添加，混合する。
【００２３】
［実施例１０］ メイクアップクリーム
（１）マイクロクリスタリンワックス ２．５（重量％）
（２）セタノール ２．０
（３）グリセリルトリ２−エチルヘキサン酸エステル １０．０
（４）モノパルミチン酸グリセリル ２．０
（５）ショ糖モノステアリン酸エステル ５．５
（６）ショ糖モノラウリン酸エステル １．０
（７）ショ糖モノミリスチン酸エステル ０．２
（８）１，３−ブチレングリコール １０．０
（９）パラオキシ安息香酸メチル ０．１
（１０）精製水 ６４．１
（１１）酸化チタン ２．０
（１２）ベンガラ ０．４
（１３）黄酸化鉄 ０．１
（１４）香料 ０．１
製法：（１）〜（４）の油相成分を混合，加熱溶解して、７５℃とする。一方、（５）〜（１０）の水相成分を混合，加熱溶解し、（１１）〜（１３）の顔料成分を添加してホモミキサーにて均一に分散して７５℃とする。次いでこの水相成分に前記油相成分を加えて混合し、ホモジナイザーにて均一に乳化する。次いで冷却し、４０℃にて（１４）を添加，混合する。
【００２４】
本発明の実施例１〜実施例１０について使用試験を行い、５℃にて１日保存した後の使用性、室温にて１年間保存した後の指へのとれと伸び、及び皮膚刺激感について評価した。その際、実施例８〜実施例１０において、それぞれ含有されるショ糖モノラウリン酸エステル，ショ糖モノミリスチン酸エステル，モノラウリン酸ヘキサグリセリル，モノラウリン酸デカグリセリル及びモノミリスチン酸デカグリセリルを、すべて精製水に代替したものを比較例４〜比較例６とし、比較例１〜比較例３とともに同時に使用試験に供した。
【００２５】
使用試験は、２０才代〜５０才代の女性パネラー２０名を１群とし、各群に実施例及び比較例のそれぞれをブラインドにて使用させて行った。５℃にて１日保存した後の使用性については、各試料を指にとって皮膚上に塗布した際に使用に耐え得るかどうかを評価させ、「充分使用に耐え得る；３点」，「やや使用しにくい；２点」，「使用に耐えない；１点」として点数化させて２０名の平均値を算出した。室温にて１年間保存した後の指へのとれと伸び、及び皮膚刺激感については、表３に示す基準に従って官能評価させて点数化し、２０名の平均値を算出して表４に示した。
【００２６】
【表３】
【表４】
表４より明らかなように、本発明の実施例については、５℃で保存した後においても、ほぼ使用に耐え得ると評価されていた。一方、比較例３以外の比較例については、５℃程度の低温下に置かれた場合に、使用性が著しく損なわれることが示されていた。また室温保存後の指へのとれ及び伸びについて、実施例使用群では全群でほぼ良好な評価が得られていた。これに対し比較例使用群では、全群において評価は低くなっていた。また、本発明の実施例使用群及び比較例使用群においては、使用時に問題となる皮膚の刺激感は認められていなかった。
【００２９】
さらに本発明の実施例１〜実施例１０については、男性パネラー３０名を１群とする４８時間の背部閉塞貼付試験においても、皮膚刺激性反応は認められなかった。
【００３０】
【発明の効果】
以上詳述したように、本発明により、ショ糖と炭素数が１６以上の直鎖飽和脂肪酸とのモノエステル、炭素数が１６以上の直鎖飽和脂肪酸のグリセリルモノエステル、及び常温で固形状を呈する油性物質を含有して成る乳化型固形化粧料における、低温下における硬度上昇や経時的な硬度上昇が改善され、製剤安定性に優れ、しかも皮膚に対し低刺激性である乳化型固形化粧料を得ることができた。[0001]
TECHNICAL FIELD OF THE INVENTION
TECHNICAL FIELD The present invention relates to an emulsified solid cosmetic which has improved formulation stability at low temperatures and improved hardness over time, has excellent formulation stability, and has low skin irritation. More specifically, (A) a monoester of sucrose and a straight-chain saturated fatty acid having 16 or more carbon atoms, (B) a glyceryl monoester of a straight-chain saturated fatty acid having 16 or more carbon atoms, and a solid at room temperature. In an emulsified cosmetic containing an oily substance, 1 is selected from the group consisting of (C) a monoester of sucrose and a fatty acid having 14 or less carbon atoms and (D) a polyglyceryl monoester of a fatty acid having 14 or less carbon atoms. The present invention relates to an emulsified solid cosmetic further comprising one or more kinds.
[0002]
[Prior art]
In emulsifying solid cosmetics represented by emollient creams, massage creams, cleansing creams, make-up creams, etc., oils and waxes that are solid at room temperature are commonly used in order to maintain the hardness of the cosmetics. . In addition, the use of nonionic surfactants such as fatty acid esters of sucrose and fatty acid esters of polyhydric alcohols such as glycerin has been studied because of their low irritation to the skin and good biodegradability. Have been. In order to maintain oxidative stability and maintain the shape of cosmetics in a solid state, fatty acids constituting these are mainly linear and saturated fatty acids having 16 or more carbon atoms.
[0003]
However, a monoester of sucrose and a linear saturated fatty acid having 16 or more carbon atoms and a glyceryl monoester of a linear saturated fatty acid having 16 or more carbon atoms are used, and further, fats and oils and waxes exhibiting a solid state at normal temperature. In the case of emulsified solid cosmetics containing such an ingredient, the hardness increases at a low temperature, and the hardness also increases over time, which has been a major problem in the stability of preparations.
[0004]
[Problems to be solved by the invention]
Therefore, in the present invention, a monoester of sucrose and a straight-chain saturated fatty acid having 16 or more carbon atoms, a glyceryl monoester of a straight-chain saturated fatty acid having 16 or more carbon atoms, and an oily substance which exhibits a solid state at normal temperature are contained. To obtain an emulsified solid cosmetic composition comprising the above-mentioned emulsified solid cosmetic composition, which suppresses an increase in hardness at a low temperature or over time as described above, has good formulation stability, and has low skin irritation. Aimed at.
[0005]
[Means for Solving the Problems]
As a result of various studies to solve the above problems, (A) a monoester of sucrose and a linear saturated fatty acid having 16 or more carbon atoms, (B) a glyceryl monoester of a linear saturated fatty acid having 16 or more carbon atoms, And (C) a monoester of sucrose and a fatty acid having a carbon number of 14 or less and (D) a polyglyceryl monoester of a fatty acid having a carbon number of 14 or less. By further containing one or more selected from the group consisting of, it is possible to effectively suppress the increase in hardness at low temperatures and the increase in hardness over time, and also find that the skin has low irritation, The present invention has been completed.
[0006]
BEST MODE FOR CARRYING OUT THE INVENTION
In the present invention, the monoester of sucrose and a linear saturated fatty acid having 16 or more carbon atoms used as the component (A) includes sucrose monopalmitate, sucrose monomalgalate, sucrose monostearate, Examples thereof include sucrose monoarachinate, sucrose monobehenate, and sucrose monolignocerate, among which those having 16 to 22 carbon atoms are preferably used.
[0007]
The glyceryl monoester of a linear saturated fatty acid having 16 or more carbon atoms used as the component (B) includes glyceryl monopalmitate, glyceryl monomalgallate, glyceryl monostearate, glyceryl monoarachiate, glyceryl monobehenate, and monolignoserine. And glyceryl acid. Among them, those having 16 to 22 carbon atoms are preferably used.
[0008]
Examples of the oily substance which exhibits a solid state at normal temperature used in the present invention include solid oils and fats such as mokuro, tallow, hardened tallow, hardened soybean oil, hardened castor oil and the like, and vegetable waxes such as carnauba wax, candelilla wax and hydrogenated jojoba oil. , Animal waxes such as beeswax, whale wax, lanolin, reduced lanolin, hard lanolin, solid hydrocarbons such as ozokerite, ceresin, microcrystalline wax, triglyceride triglyceride, glyceryl tristearate, glyceryl tripalmitate, Examples include solid fatty acid triglycerides such as glyceryl tribehenate, glyceryl trimyristate, glyceryl tricoconut oil, glyceryl trilaurate, and glyceryl trilanolin fatty acid.
[0009]
Next, in the present invention, as the monoester of sucrose and a fatty acid having 14 or less carbon atoms, which is used in combination with the above-mentioned components (A) and (B) and the oily substance which exhibits a solid state at normal temperature, is sucrose. Sugar monocaprate, sucrose monoundecanoate, sucrose monolaurate, sucrose monotridecanoate, sucrose monomyristate, sucrose monocaprolate, sucrose mono9-undecylate, sucrose Sugar mono 10-undecylenate, sucrose mono 2-laurate, sucrose monolindelate, sucrose monosuccinate, sucrose mono 5-laurate, sucrose mono 11-laurate, sucrose Mono 2-tridecene ester, sucrose mono cis-9-tridecene Ester, sucrose mono-12-tridecenoic acid esters, sucrose Monotsuzu acid ester, sucrose mono-5-myristoleic acid ester, sucrose mono-9-myristoleic acid esters. Among them, those having an HLB value of 12 or more are preferable, and those having a fatty acid having 12 to 14 carbon atoms are preferable.
[0010]
In the present invention, the polyglyceryl monoester of a fatty acid having 14 or less carbon atoms of (D) used in combination with the components (A) and (B) and an oily substance which exhibits a solid state at normal temperature includes hexaglyceryl monocaprate, Hexaglyceryl monoundecanoate, Hexaglyceryl monolaurate, Hexaglyceryl monotridecanoate, Hexaglyceryl monomyristate, Hexaglyceryl monocaprolate, Hexaglyceryl mono9-undecylenate, Hexaglyceryl mono10-undecylenate, Mono-2-lauroleic acid Hexaglyceryl, hexaglyceryl monolindelate, hexaglyceryl monosuccinate, hexaglyceryl mono-5-laurate, hexaglyceryl mono-11-lauroate, hexaglyceryl mono-2-tridecenoate, mono Hexaglyceryl is-9-tridecenoate, hexaglyceryl mono-12-tridecenoate, hexaglyceryl monotuzunate, hexaglyceryl mono-5-myristoleate, hexaglyceryl mono9-myristoleate, decaglyceryl monocaprate, deca monoundecanoate Glyceryl, decaglyceryl monolaurate, decaglyceryl monotridecanoate, decaglyceryl monomyristate, decaglyceryl monocaproleate, decaglyceryl mono9-undecylenate, decaglyceryl mono10-undecylenate, decaglyceryl mono-2-laurolate, mono Decaglyceryl lindelate, decaglyceryl monosuccinate, decaglyceryl mono-5-laurate, decaglyceryl mono-11-lauroate, decaglycerate mono-2-tridecenoate Lil, mono cis-9-tridecenoic decaglyceryl mono- 12-tridecenoic decaglyceryl, Monotsuzu decaglyceryl mono- 5- myristoleic decaglyceryl mono- 9-myristoleic decaglyceryl the like. Among them, those having an HLB value of 12 or more are preferable, and those having a fatty acid having 12 to 14 carbon atoms are preferable.
[0011]
In the present invention, one or more kinds are selected from the group consisting of the above (C) and (D), and used in combination with the components (A) and (B) and the oily substance which is solid at room temperature. In the emulsified solid cosmetic according to the present invention, the components (A) and (C) are combined at 1.0 to 10.0% by weight, and the component (B) is 1.0 to 5.0% by weight at room temperature. 1.0 to 10.0% by weight (more preferably 3.0 to 8.0% by weight) of a solid oily substance, and 0.1 to 5.0% by weight of the component (D). preferable. The weight ratio of (A) to (C) and the weight ratio of (A) to (D) are preferably set to 8: 1 to 1: 1.
[0012]
Emulsifying solid cosmetics according to the present invention include skin cosmetics such as emollient creams and massage creams, cleaning cosmetics such as cleansing creams, base cosmetics such as makeup creams and base creams, sunscreen creams and suntan creams. And sunscreen cosmetics, hair cosmetics such as hair creams, and body cosmetics such as hand creams, neck creams, and leg creams.
[0013]
Further, in the emulsified solid cosmetic according to the present invention, in addition to the components (A) to (D) and the oily substance which exhibits a solid state at ordinary temperature, oils and fats, carbonized oils and the like may be used as long as the characteristics of the present invention are not impaired. Other oily components such as hydrogen oil, ester oil, higher alcohol, other surfactants, humectants such as polyhydric alcohols and amino acids, water-soluble polymer compounds, antibacterial and fungicides, antioxidants, base components, etc. General cosmetic ingredients can be contained.
[0014]
【Example】
Further, features of the present invention will be described in detail with reference to examples.
[0015]
[Examples 1 to 7] Massage creams Examples 1 to 7 were prepared as massage creams according to the present invention by the following formulation. Simultaneously, Comparative Examples 1 to 3 were prepared.
(1) Beeswax 6.00 (% by weight)
(2) Squalane 33.00
(3) Cetyl octoate 16.00
(4) Behenyl alcohol 1.00
(5) Component shown in Table 1 Component (B) Amount shown in Table 1 (6) Component shown in Table 1 (A) Component shown in Table 1 (7) Component shown in Table 1 (C) Component shown in Table 1 (8 ) (D) component shown in Table 1) Amount shown in Table 1 (9) N-stearoyl-L-sodium glutamate 0.30
(10) 1,3-butylene glycol 6.00
(11) Carboxyvinyl polymer 0.20
(12) Methyl paraoxybenzoate 0.05
(13) L-arginine 0.25
(14) Purified water Amount to make the total amount 100.00 Production method: The oil phase components (1) to (5) are mixed, heated and dissolved, and brought to 75 ° C. (13) is dissolved in a part of (14) to form an aqueous solution. (6) to (12) are added and dissolved in the remainder of (14), heated to 75 ° C., the oil phase component is added thereto, mixed, and uniformly emulsified by a homogenizer, and the aqueous solution of (13) is added. After addition and mixing, the mixture is cooled.
[0016]
[Table 1]
With respect to Examples 1 to 7 and Comparative Examples 1 to 3, a change in hardness at a low temperature and a change in hardness over time were observed. First, each of the Examples and Comparative Examples was allowed to stand at 25 ° C. and 5 ° C. for 24 hours, and then measured for hardness with a rheometer manufactured by Fudo Kogyo Co., Ltd., and then allowed to stand at 25 ° C. for 3 months. After that, the hardness was similarly measured, and the respective measured values were compared. The results are shown in Table 2.
[0018]
[Table 2]
As for a change in hardness at a low temperature, if the hardness after standing at 5 ° C. for 24 hours exceeds 500, the usability decreases. Regarding the change with time in hardness, if the hardness after standing at 25 ° C. for 3 months exceeds 200, there is a problem in use. As is clear from Table 2, in Examples 1 to 7 of the present invention, the hardness after standing at 5 ° C. for 24 hours is 172 to 450, and the hardness after standing at 25 ° C. for 3 months. The hardness was 51 to 98, and the increase in hardness was suppressed within a range where there was no problem in use. In contrast, Comparative Examples 1 to 3 all had a hardness of more than 200 after standing at 25 ° C. for 3 months, and Comparative Examples 1 and 2 had a hardness after standing at 5 ° C. for 24 hours. A remarkable increase in hardness was also observed.
[0020]
Subsequently, the prescription of another example according to the present invention will be described.
[0021]
Example 8 Emollient Cream (1) Beeswax 6.0 (% by weight)
(2) Squalane 25.0
(3) Jojoba oil 5.0
(4) Isocetyl myristate 15.0
(5) Glyceryl monostearate 2.0
(6) Sucrose monostearate 4.0
(7) Sucrose monolaurate 1.5
(8) Decaglyceryl monolaurate 0.5
(9) 1,3-butylene glycol 6.0
(10) Glycerin 4.0
(11) Methyl paraoxybenzoate 0.1
(12) Purified water 30.7
(13) 1.0% by weight aqueous solution of sodium hyaluronate 0.1
(14) Fragrance 0.1
Production method: The oil phase components (1) to (5) are mixed and dissolved by heating to 75 ° C. On the other hand, the aqueous phase components (6) to (12) are mixed and dissolved to 75 ° C., and the oil phase component is added thereto, mixed, and uniformly emulsified by a homogenizer. Then, the mixture is cooled, (13) and (14) are added and mixed at 40 ° C.
[0022]
[Example 9] Cleansing cream (1) Carnauba wax 5.0 (% by weight)
(2) Vaseline 10.0
(3) Liquid paraffin 38.0
(4) Isopropyl myristate 10.0
(5) Glyceryl monostearate 2.5
(6) Polyoxyethylene (20EO) sorbitan 0.5
Monostearate (7) Sucrose monopalmitate 5.0
(8) Hexaglyceryl monolaurate 1.5
(9) Decaglyceryl monomyristate 1.5
(10) Propylene glycol 5.0
(11) Methyl paraoxybenzoate 0.1
(12) Purified water 20.8
(13) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating to 75 ° C. On the other hand, the aqueous phase components (7) to (12) are mixed and dissolved to 75 ° C., and the oil phase component is added thereto, mixed, and uniformly emulsified by a homogenizer. Then, the mixture is cooled and (13) is added and mixed at 40 ° C.
[0023]
[Example 10] Make-up cream (1) Microcrystalline wax 2.5 (% by weight)
(2) Cetanol 2.0
(3) Glyceryl tri-2-ethylhexanoate 10.0
(4) Glyceryl monopalmitate 2.0
(5) Sucrose monostearate 5.5
(6) Sucrose monolaurate 1.0
(7) Sucrose monomyristate 0.2
(8) 1,3-butylene glycol 10.0
(9) Methyl paraoxybenzoate 0.1
(10) Purified water 64.1
(11) Titanium oxide 2.0
(12) Bengala 0.4
(13) Yellow iron oxide 0.1
(14) Fragrance 0.1
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating to 75 ° C. On the other hand, the aqueous phase components of (5) to (10) are mixed and dissolved by heating, and the pigment components of (11) to (13) are added and uniformly dispersed by a homomixer to 75 ° C. Next, the oil phase component is added to the aqueous phase component, mixed, and uniformly emulsified by a homogenizer. Then, the mixture is cooled and (14) is added and mixed at 40 ° C.
[0024]
A usage test was conducted on Examples 1 to 10 of the present invention, and the usability after storage at 5 ° C. for one day, the removal and elongation to the finger after storage at room temperature for one year, and the feeling of skin irritation evaluated. At that time, in Examples 8 to 10, sucrose monolaurate, sucrose monomyristate, hexaglyceryl monolaurate, decaglyceryl monolaurate, and decaglyceryl monomyristate contained in purified water were all contained. The alternatives were referred to as Comparative Examples 4 to 6, and were subjected to use tests simultaneously with Comparative Examples 1 to 3.
[0025]
The use test was conducted by setting 20 female panelists in their 20s to 50s as one group, and using each of the examples and the comparative examples in a blind. With respect to the usability after storage at 5 ° C. for 1 day, each sample was evaluated for whether it was durable when applied to the finger and applied to the skin. Difficult to use; 2 points "and" Not usable; 1 point "were scored and the average value of 20 persons was calculated. After storage at room temperature for one year, the peeling and elongation to the finger and the feeling of skin irritation were scored by sensory evaluation according to the criteria shown in Table 3, and the average value of 20 persons was calculated and shown in Table 4. .
[0026]
[Table 3]
[Table 4]
As is evident from Table 4, the examples of the present invention were evaluated to be almost usable even after storage at 5 ° C. On the other hand, in Comparative Examples other than Comparative Example 3, it was shown that the usability was significantly impaired when placed at a low temperature of about 5 ° C. In addition, in the group using the examples, almost good evaluation was obtained in the group using the examples with respect to the removal and the elongation to the finger after storage at room temperature. On the other hand, in the group using the comparative example, the evaluation was low in all groups. In addition, in the group using the examples and the group using the comparative examples of the present invention, no irritating skin sensation which is a problem at the time of use was observed.
[0029]
Furthermore, in Examples 1 to 10 of the present invention, no skin irritating reaction was observed in a 48-hour back obstruction sticking test using 30 male panelists as a group.
[0030]
【The invention's effect】
As described above in detail, according to the present invention, a monoester of sucrose and a linear saturated fatty acid having 16 or more carbon atoms, a glyceryl monoester of a linear saturated fatty acid having 16 or more carbon atoms, and a solid at room temperature. Emulsion-type solid cosmetics containing an oily substance exhibiting improved hardness at low temperatures and increased hardness over time, exhibit excellent formulation stability, and have low irritation to the skin. Could be obtained.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000296372A JP3565332B2 (en) | 2000-09-28 | 2000-09-28 | Emulsion type solid cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000296372A JP3565332B2 (en) | 2000-09-28 | 2000-09-28 | Emulsion type solid cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002104927A JP2002104927A (en) | 2002-04-10 |
| JP3565332B2 true JP3565332B2 (en) | 2004-09-15 |
Family
ID=18778661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000296372A Expired - Fee Related JP3565332B2 (en) | 2000-09-28 | 2000-09-28 | Emulsion type solid cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3565332B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8409594B2 (en) | 2004-12-28 | 2013-04-02 | Otsuka Pharmaceutical Co., Ltd. | Solid oil-in-water emulsion |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3532910B2 (en) | 2002-03-26 | 2004-05-31 | 花王株式会社 | Cleansing cosmetics |
| JP4646673B2 (en) * | 2005-03-31 | 2011-03-09 | 株式会社ナリス化粧品 | Emulsified composition |
| KR101619085B1 (en) * | 2009-09-30 | 2016-05-11 | (주)아모레퍼시픽 | Cosmetic composition for massage |
| CN105769662A (en) * | 2016-03-16 | 2016-07-20 | 广州丹奇日用化工厂有限公司 | Cleansing cream with anti-allergy function and method for preparing cleansing cream |
-
2000
- 2000-09-28 JP JP2000296372A patent/JP3565332B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8409594B2 (en) | 2004-12-28 | 2013-04-02 | Otsuka Pharmaceutical Co., Ltd. | Solid oil-in-water emulsion |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002104927A (en) | 2002-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH026321B2 (en) | ||
| JPH07309717A (en) | Solid lipophilic composition and its preparation | |
| WO1996003107A1 (en) | Oil-in-water cosmetic composition | |
| JP4215918B2 (en) | Cosmetics | |
| JP2003286126A (en) | Oil-in-water type emulsified cosmetic | |
| JP2008247866A (en) | Oil-in-water emulsified cosmetic | |
| JPH0662385B2 (en) | Emulsified composition | |
| JP2000063234A (en) | Oil-in-water type cosmetic | |
| JP3565332B2 (en) | Emulsion type solid cosmetic | |
| CA2086689A1 (en) | Cosmetic or dermatological composition containing a diol ester | |
| JP2000351712A (en) | Solid water-in-oil type emulsified cosmetic | |
| JP2002212029A (en) | Oil-in-water type emulsion cosmetic for skin | |
| JP4722683B2 (en) | Emulsion composition for skin | |
| JP3774176B2 (en) | Emulsified cosmetic for hairdressing | |
| JP2001072548A (en) | Cosmetic for cleansing | |
| JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
| JP3931295B2 (en) | Emulsified cosmetic for hairdressing | |
| JP3573337B2 (en) | Emulsion cosmetic for hair | |
| JP7676747B2 (en) | Emulsified cosmetics | |
| JP2023148647A (en) | Composition for removing keratotic plugs | |
| JPH07300404A (en) | Cosmetic and / or dermatological composition and method of use thereof | |
| KR100754750B1 (en) | Oily Solid Cleansing Cosmetic Composition Containing Powder Type Anionic Surfactant | |
| JP2004067653A (en) | Emulsion cosmetic for hair dressing | |
| JP4036313B2 (en) | O / W cream emulsified cosmetic | |
| JPH10167948A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040106 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040109 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040304 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040408 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040602 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040602 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 3565332 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100618 Year of fee payment: 6 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D05 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100618 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110618 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110618 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120618 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120618 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130618 Year of fee payment: 9 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130618 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140618 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |